UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The pharmacokinetics of idraparinux, a long‐acting indirect factor Xa inhibitor: population pharmacokinetic analysis from Phase III clinical trials

Journal of thrombosis and haemostasis, 2009-04, Vol.7 (4), p.559-565

2009

Volltextzugriff (PDF)

The pharmacokinetic and pharmacodynamic effects of SL65.1498, a GABA-A 2,3 selective agonist, in comparison with lorazepam in healthy volunteers

Journal of psychopharmacology (Oxford), 2009-08, Vol.23 (6), p.625-632

2009

Volltextzugriff (PDF)

New metabolic and pharmacokinetic characteristics of thiocolchicoside and its active metabolite in healthy humans

Fundamental & clinical pharmacology, 2004-08, Vol.18 (4), p.493-501

2004

Volltextzugriff (PDF)

Pharmacokinetic profile of a new modified-release formulation of zolpidem designed to improve sleep maintenance

Clinical pharmacology and therapeutics, 2005-02, Vol.77 (2), p.P44-P44

2005

Volltextzugriff (PDF)

Population pharmacokinetic analysis and optimization of the experimental design for mizolastine solution in children

Journal of pharmacokinetics and pharmacodynamics, 2001-06, Vol.28 (3), p.299-319

2001

Volltextzugriff (PDF)

Study of cardiac repolarization in healthy volunteers performed with mizolastine, a new H1‐receptor antagonist

British journal of clinical pharmacology, 1999-05, Vol.47 (5), p.515-520

1999

Volltextzugriff (PDF)

Clinical pharmacology of befloxatone: a brief review

Journal of affective disorders, 1998-12, Vol.51 (3), p.305-312

1998

Volltextzugriff (PDF)

EEG profile of intravenous zolpidem in healthy volunteers

Psychopharmacologia, 1994-02, Vol.114 (1), p.138-146

1994

Volltextzugriff (PDF)

PK-PD relationship of the effects of argatroban on haemostasis in healthy young volunteers

Clinical pharmacology and therapeutics, 1999-02, Vol.65 (2), p.151-151

1999

Volltextzugriff (PDF)

Lack of effect of mizolastine on the safety and pharmacokinetics of digoxin administered orally in repeated doses to healthy volunteers

International journal of clinical pharmacology and therapeutics, 1998-05, Vol.36 (5), p.286

1998

Volltextzugriff (PDF)

The pharmacokinetic and pharmacodynamic effects of SL65.1498, a GABA-A alpha2,3 selective agonist, in comparison with lorazepam in healthy volunteers

Journal of psychopharmacology (Oxford), 2009-08, Vol.23 (6), p.625

2009

Volltextzugriff (PDF)

Pharmacokinetic analysis of mizolastine in healthy young volunteers after single oral and intravenous doses : Noncompartmental approach and compartmental modeling

Journal of Pharmacokinetics and Biopharmaceutics, 1997-04, Vol.25 (2), p.125-147

1997

Volltextzugriff (PDF)

The pharmacokinetic and pharmacodynamic effects of SL65.1498, a GABA-A α2,3. selective agonist, in comparison with lorazepam in healthy volunteers

Journal of psychopharmacology (Oxford), 2009, Vol.23 (6), p.625-632

2009

Volltextzugriff (PDF)

Effects of mizolastine, a new antihistamine, on psychomotor performance and memory in elderly subjects

International clinical psychopharmacology, 1994, Vol.9 (2), p.101-108

1994

Volltextzugriff (PDF)

Pharmacokinetics and bioavailability of a sustained-release diltiazem formulation (Mono-Tildiem LP 300 MG) after repeated administration in healthy volunteers

European journal of clinical pharmacology, 1995-07, Vol.48 (3-4), p.259-264

1995

Volltextzugriff (PDF)

The psychomotor and cognitive effects of litoxetine in young and middle aged volunteers

British journal of clinical pharmacology, 1995-08, Vol.40 (2), p.119-125

1995

Volltextzugriff (PDF)

Plasma and skin suction-blister-fluid pharmacokinetics and time course of the effects of oral mizolastine

European journal of clinical pharmacology, 1996, Vol.50 (4), p.327-334

1996

Volltextzugriff (PDF)

Pharmacokinetic and pharmacodynamic modeling of mizolastine in healthy volunteers with an indirect response model

Clinical pharmacology and therapeutics, 2000-12, Vol.68 (6), p.647-657

2000

Volltextzugriff (PDF)

EEG profile of litoxetine after single and repeated administration in healthy volunteers

British journal of clinical pharmacology, 1994-02, Vol.37 (2), p.157-163

1994

Volltextzugriff (PDF)

Pharmacokinetic and bioavailability of diltiazem sustained-release: influence of food and time of administration

Fundamental & clinical pharmacology, 1995-01, Vol.9 (2), p.197-201

1995

Volltextzugriff (PDF)

Study of cardiac repolarization in healthy volunteers performed with mizolastine, a new H 1 ‐receptor antagonist

British journal of clinical pharmacology, 1999-05, Vol.47 (5), p.515-520

1999

Volltextzugriff (PDF)

Clonazepam pharmacokinetics and therapeutic efficacy in neonatal seizures

European journal of clinical pharmacology, 1986-01, Vol.30 (5), p.585-589

1986

Volltextzugriff (PDF)

Determination of vincamine in human plasma using automated high-performance liquid chromatography

Journal of Chromatography A, 1981-01, Vol.204, p.335-339

1981

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of zolpidem following repeated doses in hemodialyzed uraemic patients

Fundamental & clinical pharmacology, 1993-02, Vol.7 (1), p.1-9

1993

Volltextzugriff (PDF)

Pharmacokinetics and safety of cicloprolol in uraemic patients [letter]

British journal of clinical pharmacology, 1991-08, Vol.32 (2), p.261-262

1991

Volltextzugriff (PDF)

1 – 25 von 67

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(48)

Publikationsform

Sprache

Englisch
(51)
Französisch
(16)

Erscheinungsjahr

n.n

Thema

Humans
(32)
Science & Technology
(31)
Biological And Medical Sciences
(28)
Life Sciences & Biomedicine
(28)
Medical Sciences
(28)
Pharmacology. Drug Treatments
(28)
Adult
(23)
Pharmacology & Pharmacy
(23)
Male
(20)
Cross-Over Studies
(11)
Double-Blind Method
(11)
Female
(11)
Neuropharmacology
(11)
Pharmacokinetics
(11)
Administration, Oral
(9)
Benzimidazoles - Pharmacokinetics
(9)
Psychopharmacology
(9)
Histamine H1 Antagonists - Pharmacokinetics
(8)
Psychology. Psychoanalysis. Psychiatry
(8)
Mizolastine
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The pharmacokinetics of idraparinux, a long‐acting indirect factor Xa inhibitor: population pharmacokinetic analysis from Phase III clinical trials

The pharmacokinetic and pharmacodynamic effects of SL65.1498, a GABA-A 2,3 selective agonist, in comparison with lorazepam in healthy volunteers

New metabolic and pharmacokinetic characteristics of thiocolchicoside and its active metabolite in healthy humans

Pharmacokinetic profile of a new modified-release formulation of zolpidem designed to improve sleep maintenance

Population pharmacokinetic analysis and optimization of the experimental design for mizolastine solution in children

Study of cardiac repolarization in healthy volunteers performed with mizolastine, a new H1‐receptor antagonist

Clinical pharmacology of befloxatone: a brief review

EEG profile of intravenous zolpidem in healthy volunteers

PK-PD relationship of the effects of argatroban on haemostasis in healthy young volunteers

Lack of effect of mizolastine on the safety and pharmacokinetics of digoxin administered orally in repeated doses to healthy volunteers

The pharmacokinetic and pharmacodynamic effects of SL65.1498, a GABA-A alpha2,3 selective agonist, in comparison with lorazepam in healthy volunteers

Pharmacokinetic analysis of mizolastine in healthy young volunteers after single oral and intravenous doses : Noncompartmental approach and compartmental modeling

The pharmacokinetic and pharmacodynamic effects of SL65.1498, a GABA-A α2,3. selective agonist, in comparison with lorazepam in healthy volunteers

Effects of mizolastine, a new antihistamine, on psychomotor performance and memory in elderly subjects

Pharmacokinetics and bioavailability of a sustained-release diltiazem formulation (Mono-Tildiem LP 300 MG) after repeated administration in healthy volunteers

The psychomotor and cognitive effects of litoxetine in young and middle aged volunteers

Plasma and skin suction-blister-fluid pharmacokinetics and time course of the effects of oral mizolastine

Pharmacokinetic and pharmacodynamic modeling of mizolastine in healthy volunteers with an indirect response model

EEG profile of litoxetine after single and repeated administration in healthy volunteers

Pharmacokinetic and bioavailability of diltiazem sustained-release: influence of food and time of administration

Study of cardiac repolarization in healthy volunteers performed with mizolastine, a new H 1 ‐receptor antagonist

Clonazepam pharmacokinetics and therapeutic efficacy in neonatal seizures

Determination of vincamine in human plasma using automated high-performance liquid chromatography

Pharmacokinetics and pharmacodynamics of zolpidem following repeated doses in hemodialyzed uraemic patients

Pharmacokinetics and safety of cicloprolol in uraemic patients [letter]

Suchergebnisse filtern